Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Liabilities ₹1,026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹1,026 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹1,026 Cr
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹1,026 Cr
16.58
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹319.4 Cr 10.2% 17.9% 11.2% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,668.5 Cr 2.7% 0.3% -16.3% Stock Analytics
KAVERI SEED COMPANY ₹4,755.5 Cr -0.1% 14.1% -32.8% Stock Analytics
VENKYS (INDIA) ₹2,238.8 Cr 8.9% 31% -6.2% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,052.8 Cr 1.9% 22.3% -12.9% Stock Analytics
INDO US BIOTECH ₹216.6 Cr 0.8% 8.9% -32.3% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

10.2%

17.9%

11.2%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses